Tasimelteon
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Can We Develop Glioma Subtype-Specific Precision Medicines? An Integrative Machine Learning Pipeline for Biomarker Discovery and Drug Repurposing for Glioblastoma and Low-Grade Glioma.
Journal: Omics : a journal of integrative biology
Published: December 30, 2025
Serial patent litigation: an emerging strategy to delay entry of generic competition.
Journal: Health affairs scholar
Published: November 11, 2025
Exploring Sleep Challenges and Interventions in Children with a Vision Impairment: A Scoping Review.
Exploring Sleep Challenges and Interventions in Children with a Vision Impairment: A Scoping Review.
Journal: Children (Basel, Switzerland)
Published: October 30, 2025
Correction: Effects of Tasimelteon Treatment on Traumatic Brain Injury Through NRF-2/HO-1 and RIPK1/RIPK3/MLKL Pathways in Rats.
Journal: Molecular neurobiology
Published: August 14, 2025
The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs.
Journal: Molecules (Basel, Switzerland)
Published: July 30, 2025
Assessment of drug-related migraine in a real-world large-scale database.
Journal: Frontiers in pharmacology
Published: June 14, 2025
Protective effects of tasimelteon on kidney injury in a traumatic brain injury rat model: a histopathological and immunohistochemical study.
Journal: European journal of trauma and emergency surgery : official publication of the European Trauma Society
Published: March 02, 2025
Assessment of adverse events of tasimelteon: a real-world pharmacovigilance study based on FAERS.
Journal: Expert opinion on drug safety
Published: February 10, 2025
Nitrogen Insertion via Asymmetric Condensation and Chirality Transfer: A Stereodivergent Entry to Cyanocyclopropanes.
Journal: Angewandte Chemie (International ed. in English)
Published: February 06, 2025
Neprilysin regulates the progression of glioblastoma: an in-vitro study using siRNA mediated gene silencing and HDAC1 mediated upregulation of neprilysin in U87 MG cells.
Journal: Molecular and cellular biochemistry
Published: January 16, 2025
Analysis of Tasimelteon in Pharmaceutical Formulations and Bulk Based on Design-Based Quality Approach by HPLC and Greenness Evaluation of the Method.
Journal: Journal of chromatographic science
Published: November 01, 2024
Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial.
Journal: PloS one
Published: October 16, 2024
Last Updated: 04/28/2026